Outlook Therapeutics, Inc. Gains 51.83%

Mon, Feb 08, 2021 at 05:30 PM
Outlook Therapeutics, Inc. Gains 51.83%

Outlook Therapeutics, Inc. (OTLK:NASDAQ) rocketted at $3.31, a gain of 51.8%. On Fri 05 Feb 21, OTLK:NASDAQ touched a New 2-Week High of $2.18. The stock appeared on our News Catalysts scanner on Thu 04 Feb 21 at 10:32 AM in the 'MISCELLANEOUS' category. From Fri 22 Jan 21, the stock recorded 60.00% Up Days and 54.55% Green Days

About Outlook Therapeutics, Inc. (OTLK:NASDAQ)

Oncobiologics Inc is a clinical stage biopharmaceutical company. It is focused on identifying, developing, manufacturing and commercializing complex mAb therapeutics. The company has introduced BioSymphony Platform to produce high-quality innovative and biosimilar mAb candidates in an efficient and cost-effective manner.

Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
Your price will remain at $9.99 USD after the discount period
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... or other trends? You're in the right place! Check StockTreats features.